CORI at United States

The CORI Surgical System is Smith+Nephew's compact, surgeon-controlled handheld robotics platform for orthopedic knee surgery, recorded in the surgical form factor as the handheld, imageless, smaller-footprint archetype of the orthopedic sub-cohort. Unlike Stryker's Mako, which uses a pre-operative CT scan and a large robotic arm, CORI is imageless: the surgeon paints the joint surface intra-operatively to build a three-dimensional bone model, then uses a handheld robotic bur whose cutting speed and exposure are robotically controlled to the surgical plan, with optical navigation via a passive infrared camera that Smith+Nephew states is four times faster with twice the cutting volume of the prior NAVIO system.

Because the surgeon physically holds and moves the tool throughout while the software does the imageless mapping, planning, and intra-operative tracking that governs the bur, CORI is AI-augmented surgeon-controlled assistance and not autonomous, and it is in scope as a surgical robot. Made by Smith+Nephew, listed as SN in London and SNN in New York, the system descends from Smith+Nephew's October 2015 acquisition of Blue Belt Technologies for 275 million dollars, whose NAVIO handheld system evolved into CORI at its July 14, 2020 launch alongside the Real Intelligence platform.

Its robotic-cutting scope is cleared for total, partial or unicompartmental, and revision knee, with revision knee a 2022 first-to-market indication on a robotics platform; its hip capability is navigation only, through RI.HIP NAVIGATION cleared in January 2022, and is not robotic burring, a distinction several secondary sources blur. The platform is positioned for ambulatory surgery centers and outpatient operating rooms, and no CORI-specific installed-base or procedure-volume figure is asserted here because none was verified against Smith+Nephew investor disclosure.